Zbtb20 Restrains CD8 T Cell Immunometabolism and Restricts Memory Differentiation and Antitumor Immunity

Area of Science:

• Immunology
• Cell Metabolism
• Transcriptional Regulation

Background:

• CD8 T cell differentiation involves metabolic reprogramming.
• Metabolic changes are crucial for T cell activation, proliferation, and function.
• Transcriptional regulators play key roles in orchestrating these processes.

Purpose of the Study:

• To investigate the role of Zbtb20 in regulating CD8 T cell metabolism and memory differentiation.
• To determine if Zbtb20 deficiency impacts T cell metabolic fitness and effector functions.
• To assess the potential of Zbtb20 inactivation for enhancing T cell-based immunotherapies.

Main Methods:

• Conditional Zbtb20 deficiency in mouse CD8 T cells.
• Analysis of mitochondrial and glycolytic metabolism.
• Assessment of T cell phenotype, function, and memory recall responses.
• In vivo tumor challenge models.

Main Results:

• Conditional Zbtb20 deficiency enhanced mitochondrial and glycolytic metabolism in CD8 T cells.
• Zbtb20-deficient memory CD8 T cells showed increased spare respiratory capacity and fuel flexibility.
• Zbtb20 deficiency promoted CD8 T cell differentiation towards a memory fate.
• Mice lacking Zbtb20 in CD8 T cells exhibited improved secondary responses and tumor protection.

Conclusions:

• Zbtb20 acts as a negative regulator of CD8 T cell metabolism and memory differentiation.
• Inactivating Zbtb20 enhances metabolic activity and flexibility, improving memory CD8 T cell function.
• Targeting Zbtb20 may represent a novel strategy to augment T cells for adoptive immunotherapy.